Description

17-Trifluoromethylphenyl-13,14-Dihydro Trinor Prostaglandin F2α is a high-purity synthetic prostaglandin analog, a key intermediate in advanced pharmaceutical research and development. This compound is valued for its structural specificity and bioactivity, enabling the synthesis of novel therapeutic agents targeting specific physiological pathways. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of ophthalmic solutions, dermatological treatments, and other specialized drug candidates.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel prostaglandin-based active pharmaceutical ingredients (APIs).
• Ophthalmic Research: Used in the development of next-generation treatments for glaucoma and ocular hypertension.
• Dermatological Formulations: Serves as a key precursor in the creation of topical solutions for hair growth stimulation and skin condition management.
• Biochemical Research: Employed as a reference standard and probe in studies of prostaglandin receptors and signaling pathways.
• Process Development: Utilized in scaling up and optimizing synthetic routes for prostaglandin analogs under cGMP conditions.

Basic Information

Product Name	17-Trifluoromethylphenyl-13,14-Dihydro Trinor Prostaglandin F2α
CAS No.	294856-01-2
Molecular Formula	C26H33F3O5
Molecular Weight	482.54 g/mol
Synonyms	17-(3-Trifluoromethylphenyl)-13,14-dihydro-15-keto-20-ethyl-PGF2α; 17-(3-Trifluoromethylphenyl)-13,14-dihydro-15-keto-20-ethyl-prostaglandin F2α; 17-(3-Trifluoromethylphenyl)-trinor-PGF2α ethyl amide analog; 17-TFMP-13,14-dihydro-trinor-PGF2α; Prostaglandin F2α trifluoromethylphenyl derivative; Latanoprost related compound F; Bimatoprost intermediate; Travoprost synthetic intermediate
EINECS	Contact for details

Quality Control

Our 17-Trifluoromethylphenyl-13,14-Dihydro Trinor Prostaglandin F2α is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and stringent control of residual solvents and impurities. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to ensure traceability and compliance with your research or cGMP requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere (e.g., argon or nitrogen) to prevent oxidation. Allow the sealed container to reach room temperature before opening to minimize moisture condensation. For long-term storage, keep desiccated.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.